| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014912489 |
| P356 | DOI | 10.1186/BCR1846 |
| P8608 | Fatcat ID | release_wwlcqewv4zdnlav4dqhyy3bezu |
| P3181 | OpenCitations bibliographic resource ID | 2977913 |
| P932 | PMC publication ID | 2374956 |
| P698 | PubMed publication ID | 18190691 |
| P5875 | ResearchGate publication ID | 5660260 |
| P2093 | author name string | Yong Pan | |
| Jia Le Dai | |||
| Edward J. Weinman | |||
| P2860 | cites work | Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase | Q22253438 |
| Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2 | Q22253866 | ||
| PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling | Q24303571 | ||
| The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange | Q24310009 | ||
| Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 | Q24313491 | ||
| Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity | Q24515074 | ||
| Autocrine PDGFR signaling promotes mammary cancer metastasis | Q24545375 | ||
| cAMP-mediated inhibition of the epithelial brush border Na+/H+ exchanger, NHE3, requires an associated regulatory protein | Q24569613 | ||
| Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50 | Q24683312 | ||
| Association of mammalian trp4 and phospholipase C isozymes with a PDZ domain-containing protein, NHERF | Q28138198 | ||
| Regulation of phospholipase C-beta 3 activity by Na+/H+ exchanger regulatory factor 2 | Q28140591 | ||
| G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction | Q28142079 | ||
| A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor | Q28145098 | ||
| Peptide binding consensus of the NHE‐RF‐PDZ1 domain matches the C‐terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR) | Q28272686 | ||
| An Apical PDZ Protein Anchors the Cystic Fibrosis Transmembrane Conductance Regulator to the Cytoskeleton | Q28277503 | ||
| Pten is essential for embryonic development and tumour suppression | Q28509238 | ||
| Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors | Q28510087 | ||
| Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodium-phosphate cotransporter type IIa and renal phosphate wasting | Q28510488 | ||
| Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia | Q29547900 | ||
| Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors | Q29618610 | ||
| Apoptosis in cancer | Q33846227 | ||
| CAMP-mediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor | Q33904680 | ||
| An atlas of mouse mammary gland development | Q34125577 | ||
| Inhibition of protein kinase B/Akt. implications for cancer therapy | Q34145575 | ||
| Chk1 is haploinsufficient for multiple functions critical to tumor suppression | Q34334239 | ||
| Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. | Q34370094 | ||
| Expanding the role of NHERF, a PDZ-domain containing protein adapter, to growth regulation | Q34405532 | ||
| Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction | Q34662162 | ||
| Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1) | Q35633702 | ||
| Allelotype of 28 human breast cancer cell lines and xenografts | Q36673552 | ||
| PDGF receptors as targets in tumor treatment | Q36786075 | ||
| Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. | Q38480342 | ||
| Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. | Q39706169 | ||
| Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines | Q40168416 | ||
| Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. | Q40475289 | ||
| A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration | Q40552003 | ||
| Estrogen receptor inducibility of the human Na+/H+ exchanger regulatory factor/ezrin-radixin-moesin binding protein 50 (NHE-RF/EBP50) gene involving multiple half-estrogen response elements | Q40714901 | ||
| A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. | Q43487632 | ||
| Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase | Q43726481 | ||
| Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer | Q44542378 | ||
| Haplo-insufficiency of BRCA1 in sporadic breast cancer | Q44564103 | ||
| NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer | Q45092731 | ||
| A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor | Q48129277 | ||
| Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis | Q52523693 | ||
| 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification | Q57287554 | ||
| Detailed deletion analysis of sporadic breast tumors defines an interstitial region of allelic loss on 17q25 | Q71722047 | ||
| A region of interstitial 17q25 allelic loss in ovarian tumors coincides with a defined region of loss in breast tumors | Q73337947 | ||
| Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors | Q73964420 | ||
| Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops | Q74532039 | ||
| Roles of the matrix metalloproteinases in mammary gland development and cancer | Q77579546 | ||
| Estrogen receptor regulation of the Na+/H+ exchange regulatory factor | Q77932795 | ||
| P433 | issue | 1 | |
| P921 | main subject | breast cancer | Q128581 |
| Phosphatase and tensin homolog | Q14878408 | ||
| Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | Q21496248 | ||
| P304 | page(s) | R5 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Breast Cancer Research | Q2208481 |
| P1476 | title | Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells | |
| P478 | volume | 10 |
| Q24323184 | Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling |
| Q24298046 | Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling |
| Q35140477 | E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. |
| Q22001537 | EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity |
| Q36319689 | EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation |
| Q37150777 | Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation |
| Q51065760 | Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain |
| Q36163714 | High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress |
| Q93335769 | Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells |
| Q47756210 | Involvement of platelet-derived growth factor ligands and receptors in tumorigenesis |
| Q54566655 | Microarray analysis reveals genes and functional networks relevant to the predisposition to inverted teats in pigs. |
| Q92005259 | NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland |
| Q37688175 | NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer |
| Q36288731 | NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor |
| Q34096013 | NHERF1/EBP50 in Breast Cancer: Clinical Perspectives |
| Q43238651 | NHERF1: molecular brake on the PI3K pathway in breast cancer |
| Q39459665 | Na(+)/H(+) Exchanger Regulatory Factor 1 (NHERF1) Is Required for the Estradiol-Dependent Increase of Phosphatase and Tensin Homolog (PTEN) Protein Expression |
| Q34202681 | PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control |
| Q36211287 | PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism |
| Q28115966 | PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma |
| Q36066974 | Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma |
| Q26863645 | Regulation of G Protein-Coupled Receptor Function by Na+/H+Exchange Regulatory Factors |
| Q39076960 | Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance. |
| Q91666333 | Specificity of NHERF1 regulation of GPCR signaling and function in human airway smooth muscle |
| Q47728022 | Systematic Proteogenomic Approach To Exploring a Novel Function for NHERF1 in Human Reproductive Disorder: Lessons for Exploring Missing Proteins. |
| Q37301851 | The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer. |
| Q35621438 | The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). |
| Q38714954 | The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2. |
| Q39181929 | Tumor suppressor function of ezrin-radixin-moesin-binding phosphoprotein-50 through β-catenin/E-cadher in pathway in human hepatocellular cancer |
Search more.